What Is The Current and Historic Market Size Analysis Of The Heart Transplant Market?
The heart transplant market has seen considerable growth due to a variety of factors.
• The market size for heart transplants has seen a swift expansion in the past few years. The growth is predicted to propel from $11.49 billion in 2024 to $12.66 billion in 2025, experiencing a Compound Annual Growth Rate (CAGR) of 10.2%.
The surge in this historical period can be credited to progresses in medical technologies, growth in consciousness and learning, developments in organ preservation techniques, and enhancements in healthcare facilities.
What are the Market Size and Expected Growth Rates for the Heart Transplant Market?
The heart transplant market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for heart transplants is anticipated to witness robust growth in the upcoming years, reaching a value of $18.1 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%.
The growth during this projection period can be ascribed to factors such as government assistance and funding, globalization of transplant initiatives, expansion of transplant center capacities, and the incorporation of telemedicine and remote monitoring. Key trends projected for this period include technological innovations, artificial heart and support devices, and the use of artificial intelligence (AI) in donor organ selection.
Which Key Drivers Are Propelling The Heart Transplant Market's Growth?
The expansion of the heart transplant market is expected to be driven by the increasing prevalence of cardiovascular diseases. These diseases, which affect the heart and blood vessels, necessitate a heart transplant when no other treatments are effective for people with advanced heart failure. This last-resort treatment enhances the quality of life and extends the lifespan. For example, the British Heart Foundation, a UK-based cardiovascular research charity, reported in September 2024 that about 7.6 million people, including 4 million men and 3.6 million women, are currently suffering from heart and circulatory diseases in the UK. This number is projected to grow by 1 million by 2030, and by another 2 million by 2040, which would add to the present figures. Thus, the increasing prevalence of cardiovascular diseases is expected to stimulate the heart transplant market. Concerning another driver, the heart transplant market is projected to grow due to the mounting awareness surrounding organ donation and transplantation. This awareness is a measure of the knowledge, consciousness, and understanding individuals and communities have about organ donation and transplantation, including its processes, significance, and influence in healthcare. Heightened awareness can positively impact heart transplants by enlarging the donor pool, reducing recipient waiting times, and improving patient results. For instance, the United Network for Organ Sharing, a scientific and educational non-profit organization based in the US, reported a new annual record of 42,887 organ transplants in the US in 2022, which represented a 3.7% increase from 2021. This growth was attributed to established awareness, leading to 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants. Hence, the intensified awareness of organ donation and transplantation is likely to fuel the heart transplant market.
What Are The Key Segments Within The Global Heart Transplant Market?
The heart transplant market covered in this report is segmented –
1) By Surgery Type: Total Artificial Heart, Biventricular Pacing, Ventricular Assist Devices, Other Surgery Types
2) By Transplant: Autograft, Allograft, Other Transplants
3) By End-User: Hospitals, Cardiac Institutes, Other End-Users
Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart, Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P), Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant, Heterotopic Heart Transplant
Pre-Book The Heart Transplant Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Heart Transplant Market?
Key players in the heart transplant market are prioritizing the creation of groundbreaking strategies such as heart preservation technology to enhance patient results and overall transplant success. This technology notably prolongs the time the heart can be kept outside the body as compared to conventional ice storage, leading to better post-transplant results and fewer complications. For example, in May 2023, Xvivo Perfusion AB, a medical technology firm based in Sweden, received U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application for its heart preservation technology, paving the way for the initiation of the "PRESERVE Clinical Trial." This is a single-arm, multicenter, open-label, prospective study primarily aimed at assessing hearts transplanted after non-ischemic heart preservation involving extended donors, particularly those involving Donation after Circulatory Death (DCD) hearts. XVIVO's heart preservation technology is exceptionally unique due to its non-ischemic hypothermic perfusion system, which uses oxygenated cold perfusion to maintain donor hearts during transportation.
Who Are the Key Players In The Heart Transplant Market?
Major companies operating in the heart transplant market are:
• Optum Inc.
• Novartis Pharmaceuticals UK Ltd.
• Abbott Laboratories
• Medtronic PLC
• Stryker Corporation
• Roche Diagnostics Ltd.
• Mayo Clinic
• Cleveland Clinic
• AstraZeneca PLC
• Massachusetts General Hospital
• Terumo Corp.
• NewYork-Presbyterian Hospital
• Cedars-Sinai Medical Center
• Maquet Holding B.V. and Co. KG.
• Teleflex Inc.
• Stanford Health Care
• Johns Hopkins Hospital
• Thoratec Corporation
• Abiomed Inc.
• Baylor St. Lukes Medical Center
• Transonic Systems Inc.
• Berlin Heart GmbH
• HeartWare International Inc.
• SynCardia Systems LLC.
• Carmat SA
• BiVACOR Inc.
• Apaxis Medical Inc.
• Calon Cardio-Technology Ltd.
• CardiacAssist Inc.
• The Texas Heart Institute.
What Are The Regional Insights Into The Heart Transplant Market?
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
